Source link : https://las-vegas-news.com/purdue-pharma-sentencing-looms-225-million-forfeiture-set-to-unlock-opioid-crisis-settlements/
Purdue’s Admissions Ignite Renewed Scrutiny (Image Credits: Pexels)
Newark, New Jersey — A federal judge stands ready to sentence OxyContin maker Purdue Pharma on longstanding criminal charges tied to the opioid epidemic. The ruling, scheduled for Tuesday afternoon via videoconference, requires the company to forfeit $225 million to the Justice Department.[1][2] This step finalizes a pivotal plea deal and paves the way for billions in settlement funds to reach states, localities, and victims from thousands of lawsuits.
Purdue’s Admissions Ignite Renewed Scrutiny
The company shocked observers in November 2020 when it pleaded guilty to three felony counts: a dual conspiracy to defraud the United States and violate the Food, Drug, and Cosmetic Act, plus two counts of violating the federal Anti-Kickback Statute.[1] Prosecutors detailed how Purdue misled the Drug Enforcement Administration about its anti-diversion efforts while marketing opioids to over 100 suspect providers.
Executives pushed prescriptions through illicit channels, including speaker programs that paid doctors for endorsements and deals with an electronic health records firm to nudge more opioid orders.[2] These tactics fueled a crisis that has claimed over 900,000 lives since 1999. Though Purdue produced a small share of pills, its OxyContin sales became a symbol of aggressive promotion.[2]
Unpacking the Plea Deal’s Financial Terms
The agreement called for a $3.544 billion criminal fine and $2…
—-
Author : Matthias Binder
Publish date : 2026-04-21 14:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8